EMEA (Europe, Middle East and Africa) Docetaxel Market Report 2017

January 2018 | 112 pages | ID: EF3F56E8617EN
QYResearch

Abstracts

In this report, the EMEA Docetaxel market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Docetaxel for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Docetaxel market competition by top manufacturers/players, with Docetaxel sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Sanofi-Aventis
• Pfizer
• Teva
• Taj Pharmaceuticals
• Dr. Reddy
• Sandoz
• Actavis
• Sun pharma
• Beijing Union Pharmaceutical
• Cisen Pharmaceutical
• Qilu Pharma
• Taiji Group
• Jiangsu Hengrui
• Accord Healthcare
• Eagle Pharmaceuticals

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• 40 mg/ml
• 20 mg/ml
• 10 mg/ml

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Breast cancer
• Non-small cell lung cancer
• Prostate cancer
• Gastric adenocarcinoma cancer
• Head and neck cancer

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Docetaxel Market Report 2017

1 DOCETAXEL OVERVIEW

1.1 Product Overview and Scope of Docetaxel
1.2 Classification of Docetaxel
  1.2.1 EMEA Docetaxel Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Docetaxel Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 40 mg/ml
  1.2.4 20 mg/ml
  1.2.5 10 mg/ml
1.3 EMEA Docetaxel Market by Application/End Users
  1.3.1 EMEA Docetaxel Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Breast cancer
  1.3.3 Non-small cell lung cancer
  1.3.4 Prostate cancer
  1.3.5 Gastric adenocarcinoma cancer
  1.3.6 Head and neck cancer
1.4 EMEA Docetaxel Market by Region
  1.4.1 EMEA Docetaxel Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Docetaxel (2012-2022)
  1.5.1 EMEA Docetaxel Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Docetaxel Revenue and Growth Rate (2012-2022)

2 EMEA DOCETAXEL COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Docetaxel Market Competition by Players/Manufacturers
  2.1.1 EMEA Docetaxel Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Docetaxel Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Docetaxel Sale Price by Players (2012-2017)
2.2 EMEA Docetaxel (Volume and Value) by Type/Product Category
  2.2.1 EMEA Docetaxel Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Docetaxel Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Docetaxel Sale Price by Type (2012-2017)
2.3 EMEA Docetaxel (Volume) by Application
2.4 EMEA Docetaxel (Volume and Value) by Region
  2.4.1 EMEA Docetaxel Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Docetaxel Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Docetaxel Sales Price by Region (2012-2017)

3 EUROPE DOCETAXEL (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Docetaxel Sales and Value (2012-2017)
  3.1.1 Europe Docetaxel Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Docetaxel Revenue and Growth Rate (2012-2017)
3.2 Europe Docetaxel Sales and Market Share by Type
3.3 Europe Docetaxel Sales and Market Share by Application
3.4 Europe Docetaxel Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Docetaxel Sales Volume by Countries (2012-2017)
  3.4.2 Europe Docetaxel Revenue by Countries (2012-2017)
  3.4.3 Germany Docetaxel Sales and Growth Rate (2012-2017)
  3.4.4 France Docetaxel Sales and Growth Rate (2012-2017)
  3.4.5 UK Docetaxel Sales and Growth Rate (2012-2017)
  3.4.6 Russia Docetaxel Sales and Growth Rate (2012-2017)
  3.4.7 Italy Docetaxel Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Docetaxel Sales and Growth Rate (2012-2017)

4 MIDDLE EAST DOCETAXEL (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Docetaxel Sales and Value (2012-2017)
  4.1.1 Middle East Docetaxel Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Docetaxel Revenue and Growth Rate (2012-2017)
4.2 Middle East Docetaxel Sales and Market Share by Type
4.3 Middle East Docetaxel Sales and Market Share by Application
4.4 Middle East Docetaxel Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Docetaxel Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Docetaxel Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Docetaxel Sales and Growth Rate (2012-2017)
  4.4.4 Israel Docetaxel Sales and Growth Rate (2012-2017)
  4.4.5 UAE Docetaxel Sales and Growth Rate (2012-2017)
  4.4.6 Iran Docetaxel Sales and Growth Rate (2012-2017)

5 AFRICA DOCETAXEL (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Docetaxel Sales and Value (2012-2017)
  5.1.1 Africa Docetaxel Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Docetaxel Revenue and Growth Rate (2012-2017)
5.2 Africa Docetaxel Sales and Market Share by Type
5.3 Africa Docetaxel Sales and Market Share by Application
5.4 Africa Docetaxel Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Docetaxel Sales Volume by Countries (2012-2017)
  5.4.2 Africa Docetaxel Revenue by Countries (2012-2017)
  5.4.3 South Africa Docetaxel Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Docetaxel Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Docetaxel Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Docetaxel Sales and Growth Rate (2012-2017)

6 EMEA DOCETAXEL MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Sanofi-Aventis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Docetaxel Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi-Aventis Docetaxel Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Pfizer
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Docetaxel Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer Docetaxel Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Teva
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Docetaxel Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Teva Docetaxel Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Taj Pharmaceuticals
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Docetaxel Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Taj Pharmaceuticals Docetaxel Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Dr. Reddy
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Docetaxel Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Dr. Reddy Docetaxel Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Sandoz
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Docetaxel Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sandoz Docetaxel Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Actavis
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Docetaxel Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Actavis Docetaxel Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Sun pharma
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Docetaxel Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Sun pharma Docetaxel Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Beijing Union Pharmaceutical
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Docetaxel Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Beijing Union Pharmaceutical Docetaxel Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Cisen Pharmaceutical
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Docetaxel Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Cisen Pharmaceutical Docetaxel Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Qilu Pharma
6.12 Taiji Group
6.13 Jiangsu Hengrui
6.14 Accord Healthcare
6.15 Eagle Pharmaceuticals

7 DOCETAXEL MANUFACTURING COST ANALYSIS

7.1 Docetaxel Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Docetaxel

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Docetaxel Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Docetaxel Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA DOCETAXEL MARKET FORECAST (2017-2022)

11.1 EMEA Docetaxel Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Docetaxel Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Docetaxel Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Docetaxel Price and Trend Forecast (2017-2022)
11.2 EMEA Docetaxel Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Docetaxel Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Docetaxel Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Docetaxel Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Docetaxel Sales Forecast by Type (2017-2022)
11.7 EMEA Docetaxel Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Docetaxel
Figure EMEA Docetaxel Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Docetaxel Sales Volume Market Share by Type (Product Category) in 2016
Figure 40 mg/ml Product Picture
Figure 20 mg/ml Product Picture
Figure 10 mg/ml Product Picture
Figure EMEA Docetaxel Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Docetaxel by Application in 2016
Figure Breast cancer Examples
Table Key Downstream Customer in Breast cancer
Figure Non-small cell lung cancer Examples
Table Key Downstream Customer in Non-small cell lung cancer
Figure Prostate cancer Examples
Table Key Downstream Customer in Prostate cancer
Figure Gastric adenocarcinoma cancer Examples
Table Key Downstream Customer in Gastric adenocarcinoma cancer
Figure Head and neck cancer Examples
Table Key Downstream Customer in Head and neck cancer
Figure EMEA Docetaxel Market Size (Million USD) by Region (2012-2022)
Figure Europe Docetaxel Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Docetaxel Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Docetaxel Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Docetaxel Revenue (Million USD) Status and Forecast by Countries
Figure Africa Docetaxel Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Docetaxel Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Docetaxel Sales Volume and Growth Rate (2012-2022)
Figure EMEA Docetaxel Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Docetaxel Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Docetaxel Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Docetaxel Sales Share by Players (2012-2017)
Figure 2016 Docetaxel Sales Share by Players
Figure 2017 Docetaxel Sales Share by Players
Figure EMEA Docetaxel Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Docetaxel Revenue (Million USD) by Players (2012-2017)
Table EMEA Docetaxel Revenue Share by Players (2012-2017)
Table 2016 EMEA Docetaxel Revenue Share by Players
Table 2017 EMEA Docetaxel Revenue Share by Players
Table EMEA Docetaxel Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Docetaxel Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Docetaxel Sales Share by Type (2012-2017)
Figure Sales Market Share of Docetaxel by Type (2012-2017)
Figure EMEA Docetaxel Sales Market Share by Type (2012-2017)
Table EMEA Docetaxel Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Docetaxel Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Docetaxel by Type in 2016
Table EMEA Docetaxel Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Docetaxel Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Docetaxel Sales Share by Application (2012-2017)
Figure Sales Market Share of Docetaxel by Application (2012-2017)
Figure EMEA Docetaxel Sales Market Share by Application in 2016
Table EMEA Docetaxel Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Docetaxel Sales Share by Region (2012-2017)
Figure Sales Market Share of Docetaxel by Region (2012-2017)
Figure EMEA Docetaxel Sales Market Share in 2016
Table EMEA Docetaxel Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Docetaxel Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Docetaxel by Region (2012-2017)
Figure EMEA Docetaxel Revenue Market Share Regions in 2016
Table EMEA Docetaxel Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Docetaxel Revenue and Growth Rate (2012-2017)
Table Europe Docetaxel Sales (K Units) by Type (2012-2017)
Table Europe Docetaxel Market Share by Type (2012-2017)
Figure Europe Docetaxel Market Share by Type in 2016
Table Europe Docetaxel Sales (K Units) by Application (2012-2017)
Table Europe Docetaxel Market Share by Application (2012-2017)
Figure Europe Docetaxel Market Share by Application in 2016
Table Europe Docetaxel Sales (K Units) by Countries (2012-2017)
Table Europe Docetaxel Sales Market Share by Countries (2012-2017)
Figure Europe Docetaxel Sales Market Share by Countries (2012-2017)
Figure Europe Docetaxel Sales Market Share by Countries in 2016
Table Europe Docetaxel Revenue (Million USD) by Countries (2012-2017)
Table Europe Docetaxel Revenue Market Share by Countries (2012-2017)
Figure Europe Docetaxel Revenue Market Share by Countries (2012-2017)
Figure Europe Docetaxel Revenue Market Share by Countries in 2016
Figure Germany Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure France Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure UK Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Docetaxel Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Docetaxel Sales (K Units) by Type (2012-2017)
Table Middle East Docetaxel Market Share by Type (2012-2017)
Figure Middle East Docetaxel Market Share by Type (2012-2017)
Table Middle East Docetaxel Sales (K Units) by Applications (2012-2017)
Table Middle East Docetaxel Market Share by Applications (2012-2017)
Figure Middle East Docetaxel Sales Market Share by Application in 2016
Table Middle East Docetaxel Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Docetaxel Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Docetaxel Sales Volume Market Share by Countries in 2016
Table Middle East Docetaxel Revenue (Million USD) by Countries (2012-2017)
Table Middle East Docetaxel Revenue Market Share by Countries (2012-2017)
Figure Middle East Docetaxel Revenue Market Share by Countries (2012-2017)
Figure Middle East Docetaxel Revenue Market Share by Countries in 2016
Figure Saudi Arabia Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Docetaxel Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Docetaxel Sales (K Units) by Type (2012-2017)
Table Africa Docetaxel Sales Market Share by Type (2012-2017)
Figure Africa Docetaxel Sales Market Share by Type (2012-2017)
Figure Africa Docetaxel Sales Market Share by Type in 2016
Table Africa Docetaxel Sales (K Units) by Application (2012-2017)
Table Africa Docetaxel Sales Market Share by Application (2012-2017)
Figure Africa Docetaxel Sales Market Share by Application (2012-2017)
Table Africa Docetaxel Sales Volume (K Units) by Countries (2012-2017)
Table Africa Docetaxel Sales Market Share by Countries (2012-2017)
Figure Africa Docetaxel Sales Market Share by Countries (2012-2017)
Figure Africa Docetaxel Sales Market Share by Countries in 2016
Table Africa Docetaxel Revenue (Million USD) by Countries (2012-2017)
Table Africa Docetaxel Revenue Market Share by Countries (2012-2017)
Figure Africa Docetaxel Revenue Market Share by Countries (2012-2017)
Figure Africa Docetaxel Revenue Market Share by Countries in 2016
Figure South Africa Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Table Sanofi-Aventis Docetaxel Basic Information List
Table Sanofi-Aventis Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi-Aventis Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi-Aventis Docetaxel Sales Market Share in EMEA (2012-2017)
Figure Sanofi-Aventis Docetaxel Revenue Market Share in EMEA (2012-2017)
Table Pfizer Docetaxel Basic Information List
Table Pfizer Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Docetaxel Sales Market Share in EMEA (2012-2017)
Figure Pfizer Docetaxel Revenue Market Share in EMEA (2012-2017)
Table Teva Docetaxel Basic Information List
Table Teva Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Teva Docetaxel Sales Market Share in EMEA (2012-2017)
Figure Teva Docetaxel Revenue Market Share in EMEA (2012-2017)
Table Taj Pharmaceuticals Docetaxel Basic Information List
Table Taj Pharmaceuticals Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Taj Pharmaceuticals Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Taj Pharmaceuticals Docetaxel Sales Market Share in EMEA (2012-2017)
Figure Taj Pharmaceuticals Docetaxel Revenue Market Share in EMEA (2012-2017)
Table Dr. Reddy Docetaxel Basic Information List
Table Dr. Reddy Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dr. Reddy Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Dr. Reddy Docetaxel Sales Market Share in EMEA (2012-2017)
Figure Dr. Reddy Docetaxel Revenue Market Share in EMEA (2012-2017)
Table Sandoz Docetaxel Basic Information List
Table Sandoz Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sandoz Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Sandoz Docetaxel Sales Market Share in EMEA (2012-2017)
Figure Sandoz Docetaxel Revenue Market Share in EMEA (2012-2017)
Table Actavis Docetaxel Basic Information List
Table Actavis Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Actavis Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Actavis Docetaxel Sales Market Share in EMEA (2012-2017)
Figure Actavis Docetaxel Revenue Market Share in EMEA (2012-2017)
Table Sun pharma Docetaxel Basic Information List
Table Sun pharma Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sun pharma Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Sun pharma Docetaxel Sales Market Share in EMEA (2012-2017)
Figure Sun pharma Docetaxel Revenue Market Share in EMEA (2012-2017)
Table Beijing Union Pharmaceutical Docetaxel Basic Information List
Table Beijing Union Pharmaceutical Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Beijing Union Pharmaceutical Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Beijing Union Pharmaceutical Docetaxel Sales Market Share in EMEA (2012-2017)
Figure Beijing Union Pharmaceutical Docetaxel Revenue Market Share in EMEA (2012-2017)
Table Cisen Pharmaceutical Docetaxel Basic Information List
Table Cisen Pharmaceutical Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cisen Pharmaceutical Docetaxel Sales (K Units) and Growth Rate (2012-2017)
Figure Cisen Pharmaceutical Docetaxel Sales Market Share in EMEA (2012-2017)
Figure Cisen Pharmaceutical Docetaxel Revenue Market Share in EMEA (2012-2017)
Table Qilu Pharma Docetaxel Basic Information List
Table Taiji Group Docetaxel Basic Information List
Table Jiangsu Hengrui Docetaxel Basic Information List
Table Accord Healthcare Docetaxel Basic Information List
Table Eagle Pharmaceuticals Docetaxel Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Docetaxel
Figure Manufacturing Process Analysis of Docetaxel
Figure Docetaxel Industrial Chain Analysis
Table Raw Materials Sources of Docetaxel Major Manufacturers in 2016
Table Major Buyers of Docetaxel
Table Distributors/Traders List
Figure EMEA Docetaxel Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Docetaxel Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Docetaxel Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Docetaxel Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Docetaxel Sales Market Share Forecast by Region (2017-2022)
Table EMEA Docetaxel Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Docetaxel Revenue Market Share Forecast by Region (2017-2022)
Table Europe Docetaxel Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Docetaxel Sales Market Share Forecast by Countries (2017-2022)
Table Europe Docetaxel Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Docetaxel Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Docetaxel Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Docetaxel Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Docetaxel Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Docetaxel Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Docetaxel Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Docetaxel Sales Market Share Forecast by Countries (2017-2022)
Table Africa Docetaxel Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Docetaxel Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Docetaxel Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Docetaxel Sales Market Share Forecast by Type (2017-2022)
Table EMEA Docetaxel Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Docetaxel Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources